None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Among all men and women aged between 19 and 65 years who meet the criteria of BMI>23kg/m2
Exclusion criteria
Exclusion criteria: 1)women with any condition that can affect weight gain such as hypothyroidism, cushing syndrome 2)heart disease(heart failure, angina pectoris, myocardial infarction) 3)cancer or lung disease 4)liver dysfunction(ALT, AST = 2.5 fold upper limit of normal) 5)women who are diagnosed with cholelithiasis 6)severe renal dysfunction (Cr >2.0mg/dl) 7)Narrow angle glaucoma 8)neuropsychiatric diseases(schizophrenia, epilepsy, alcoholism, drug addiction, anorexia nervosa, hyperphagia) 9)past history of stroke, transient ischemic heart disease 10)eating disorder such as anorexia nervosa and bulimia nervosa 11)women who have taken anorexiants, relievers(without prescription), oral steroid, thyroid hormone, amphetamine, cyproheptadine, phenothiazine, or any other medication within 3 months that can affect absorption, metabolism, excretion which can affect on weight. 12)who are on narcotics and neuropsychological drugs for weight reduction 13)other forbidden treatments(insulin, hypogycemic agents, antidepressants, anti serotonin reuptake inhibitor, sodium pentobarbital, antipsychotics, drugs concerned with misuse) 14)women who underwent anatomical change such as incision which makes it difficult to conduct physical measurements 15)women who underwent surgeries for weiight reduction(gastroplastia) 16)pregnant women, breast feeder, women planning a pregnancy and those who do not agree to use adequate contraception such as oral contraceptives, hormone transplant, IUD, spermicide, condom, celibacy. 17)women who have taken other medications provided by clinical trial within a month 18)women who have lost more than 10% of body weight within 6 months 19)women who are judged to be unacceptable for candidate by person in charge of clinical trial 20)women who have given up on smoking within past 3 months but who have irregular smoking habit
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| difference of intestinal microbiota ratio according to Sasang typology and herbal medicine group;difference of intestinal permeability (Lactulose mannitol ratio) according to Sasang typology and herbal medicine group | — |
Secondary
| Measure | Time frame |
|---|---|
| weight;body composition (body fat mass, muscle mass);blood lipid profile (triglyceride, total cholesterol, HDL cholesterol);waist circumference;blood pressure;blood glucose;BMI (Body mass index) | — |
Countries
Korea, Republic of
Contacts
Dongguk University Ilsan Hospital